TMEM72
geneOn this page
Also known as bA285G1.3KSP37
Summary
TMEM72 (transmembrane protein 72, HGNC:31658) is a protein-coding gene on chromosome 10q11.21, encoding Transmembrane protein 72 (A0PK05).
This gene encodes a transmembrane protein which may be expressed specifically in the kidney.
Source: NCBI Gene 643236 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 6 total
- MANE Select transcript:
NM_001123376
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31658 |
| Approved symbol | TMEM72 |
| Name | transmembrane protein 72 |
| Location | 10q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA285G1.3, KSP37 |
| Ensembl gene | ENSG00000187783 |
| Ensembl biotype | protein_coding |
| Entrez | 643236 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000389583, ENST00000460364, ENST00000544540
RefSeq mRNA: 2 — MANE Select: NM_001123376
NM_001123376, NM_001345926
CCDS: CCDS41504, CCDS86085
Canonical transcript exons
ENST00000389583 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001364709 | 44911337 | 44911582 |
| ENSE00001368456 | 44927921 | 44927987 |
| ENSE00001506285 | 44934656 | 44937010 |
| ENSE00003481770 | 44931998 | 44932069 |
| ENSE00003579824 | 44933637 | 44933776 |
Expression profiles
Bgee: expression breadth ubiquitous, 108 present calls, max score 93.83.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2348 / max 91.6736, expressed in 58 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 104770 | 0.0618 | 19 |
| 104769 | 0.0579 | 24 |
| 104768 | 0.0527 | 18 |
| 104772 | 0.0446 | 7 |
| 104773 | 0.0116 | 3 |
| 104771 | 0.0063 | 3 |
Top tissues by expression
199 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| renal medulla | UBERON:0000362 | 93.83 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 91.70 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 91.03 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 89.95 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.50 | gold quality |
| kidney | UBERON:0002113 | 89.39 | gold quality |
| sperm | CL:0000019 | 85.19 | gold quality |
| metanephros | UBERON:0000081 | 83.12 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.74 | gold quality |
| cortex of kidney | UBERON:0001225 | 82.60 | gold quality |
| cerebellar vermis | UBERON:0004720 | 81.10 | silver quality |
| subthalamic nucleus | UBERON:0001906 | 79.83 | silver quality |
| vena cava | UBERON:0004087 | 78.99 | gold quality |
| rectum | UBERON:0001052 | 78.55 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 78.44 | silver quality |
| ventral tegmental area | UBERON:0002691 | 78.18 | silver quality |
| inferior vagus X ganglion | UBERON:0005363 | 78.10 | silver quality |
| substantia nigra pars reticulata | UBERON:0001966 | 78.05 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 77.91 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 77.68 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 77.68 | silver quality |
| cardia of stomach | UBERON:0001162 | 77.67 | gold quality |
| tongue | UBERON:0001723 | 77.64 | silver quality |
| body of tongue | UBERON:0011876 | 77.63 | silver quality |
| lateral globus pallidus | UBERON:0002476 | 77.48 | silver quality |
| pharyngeal mucosa | UBERON:0000355 | 77.46 | silver quality |
| superior surface of tongue | UBERON:0007371 | 77.44 | silver quality |
| pericardium | UBERON:0002407 | 77.26 | silver quality |
| trachea | UBERON:0003126 | 77.15 | silver quality |
| dorsal root ganglion | UBERON:0000044 | 77.13 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-119 | yes | 40.11 |
| E-ANND-3 | no | 1.43 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
79 targeting TMEM72, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-221-5P | 99.86 | 65.45 | 1052 |
| HSA-MIR-8073 | 99.86 | 65.21 | 1118 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-670-5P | 99.67 | 69.94 | 1565 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-6752-5P | 99.59 | 67.32 | 1243 |
| HSA-MIR-5580-5P | 99.38 | 66.96 | 1139 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-6128 | 99.33 | 67.83 | 1581 |
| HSA-MIR-3678-3P | 99.31 | 67.10 | 1432 |
| HSA-MIR-6719-3P | 99.29 | 67.78 | 1387 |
| HSA-MIR-10522-5P | 99.26 | 68.50 | 2087 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-4292 | 99.16 | 65.57 | 1767 |
| HSA-MIR-6791-5P | 99.16 | 65.92 | 1844 |
| HSA-MIR-6815-3P | 99.13 | 68.98 | 1530 |
Literature-anchored findings (GeneRIF, showing 1)
- ER export signals mediate plasma membrane localization of transmembrane protein TMEM72. (PMID:36478074)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem72 | ENSDARG00000069332 |
| mus_musculus | Tmem72 | ENSMUSG00000048108 |
| rattus_norvegicus | Tmem72 | ENSRNOG00000023340 |
Protein
Protein identifiers
Transmembrane protein 72 — A0PK05 (reviewed: A0PK05)
Alternative names: Kidney-specific secretory protein of 37 kDa
All UniProt accessions (1): A0PK05
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cell membrane. Early endosome membrane Cytoplasm. Nucleus.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A0PK05-1 | 1 | yes |
| A0PK05-2 | 2 |
RefSeq proteins (2): NP_001116848, NP_001332855 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032055 | TMEM72 | Family |
Pfam: PF16054
UniProt features (13 total): topological domain 4, transmembrane region 3, compositionally biased region 2, region of interest 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0PK05-F1 | 57.48 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
SABATES_COLORECTAL_ADENOMA_DN, LEIN_CHOROID_PLEXUS_MARKERS, GOCC_EARLY_ENDOSOME_MEMBRANE, DODD_NASOPHARYNGEAL_CARCINOMA_DN, CHYLA_CBFA2T3_TARGETS_DN, GOCC_ENDOSOME_MEMBRANE, MIR1299, MIR670_5P, MIR6728_3P, MIR6747_3P, MIR5580_5P, MIR3127_3P, MIR6756_3P, MIR4659B_5P, MIR3194_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), cytoplasm (GO:0005737), plasma membrane (GO:0005886), membrane (GO:0016020), early endosome membrane (GO:0031901)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| early endosome | 1 |
| endosome membrane | 1 |
Protein interactions and networks
STRING
480 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM72 | TMEM116 | Q8NCL8 | 623 |
| TMEM72 | RNF181 | Q9P0P0 | 476 |
| TMEM72 | TMEM213 | A2RRL7 | 447 |
| TMEM72 | C7orf57 | Q8NEG2 | 446 |
| TMEM72 | INSYN2B | A6NMK8 | 435 |
| TMEM72 | TMEM61 | Q8N0U2 | 400 |
| TMEM72 | SMIM13 | P0DJ93 | 394 |
| TMEM72 | RDM1 | Q8NG50 | 379 |
| TMEM72 | TRAPPC13 | A5PLN9 | 376 |
| TMEM72 | ERICH6 | Q7L0X2 | 374 |
| TMEM72 | C22orf42 | Q6IC83 | 374 |
| TMEM72 | TMEM207 | Q6UWW9 | 371 |
| TMEM72 | RTP3 | Q9BQQ7 | 370 |
| TMEM72 | OR13A1 | Q8NGR1 | 370 |
| TMEM72 | LUZP2 | Q86TE4 | 367 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MS4A1 | TMEM72 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | SLC35A5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | BCL2L13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | LENEP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | PIGY | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | FAM209A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | GJA8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | MS4A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | CERS4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | FXYD6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM72 | MGST3 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM72 | BCL2L13 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM72 | LENEP | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM72 | GJA8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM72 | CERS4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM72 | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FXYD6 | TMEM72 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM72 | PIGY | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM72 | FAM209A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (40): TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), TMEM72 (Two-hybrid), PIGY (Two-hybrid), GGCX (Affinity Capture-MS), SYNJ2BP (Affinity Capture-MS), PTDSS2 (Affinity Capture-MS), SLC1A1 (Affinity Capture-MS), APOB (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GRQ0, A0A1B0GSZ0, A0A1B0GVT2, A0A590UK83, A0PK05, A2VDU1, A2VE22, A4QNL6, A5D7B5, A5D992, O43609, O75324, P0DKX4, P29414, P61807, P61808, Q0VFM5, Q15053, Q16655, Q17Q87, Q1L0X2, Q2KIK3, Q2TBG9, Q3MHM8, Q498C7, Q4V921, Q58CU5, Q5RBD8, Q5RF07, Q5RGQ8, Q64448, Q6UWT2, Q80ZU4, Q8BGN6, Q8BUM6, Q8C3K5, Q8C817, Q8K1D8, Q8N6S5, Q91VT8
Diamond homologs: A0PK05, Q8C3K5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1774 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:44933734:T:C | C103R | 0.982 |
| 10:44934656:G:A | G117D | 0.981 |
| 10:44933737:T:C | F104L | 0.980 |
| 10:44933739:C:A | F104L | 0.980 |
| 10:44933739:C:G | F104L | 0.980 |
| 10:44933758:T:A | W111R | 0.979 |
| 10:44933758:T:C | W111R | 0.979 |
| 10:44933776:G:C | G117R | 0.978 |
| 10:44933704:T:C | F93L | 0.975 |
| 10:44933706:C:A | F93L | 0.975 |
| 10:44933706:C:G | F93L | 0.975 |
| 10:44934665:T:A | L120H | 0.972 |
| 10:44934676:G:C | G124R | 0.972 |
| 10:44911564:G:C | G18R | 0.970 |
| 10:44927936:G:A | G29D | 0.969 |
| 10:44927984:T:C | L45P | 0.969 |
| 10:44933736:C:G | C103W | 0.969 |
| 10:44927935:G:C | G29R | 0.968 |
| 10:44933760:G:C | W111C | 0.965 |
| 10:44933760:G:T | W111C | 0.965 |
| 10:44933771:T:C | I115T | 0.963 |
| 10:44934677:G:A | G124D | 0.962 |
| 10:44932005:G:A | G49R | 0.960 |
| 10:44932005:G:C | G49R | 0.960 |
| 10:44933771:T:A | I115N | 0.958 |
| 10:44933738:T:C | F104S | 0.957 |
| 10:44934817:T:C | F171L | 0.956 |
| 10:44934819:C:A | F171L | 0.956 |
| 10:44934819:C:G | F171L | 0.956 |
| 10:44933774:C:G | P116R | 0.954 |
dbSNP variants (sampled 300 via entrez): RS1000060769 (10:44915276 T>A), RS1000178908 (10:44911828 C>T), RS1000195169 (10:44921122 C>A), RS1000344360 (10:44926643 C>G), RS1000345928 (10:44924486 CAGA>C), RS1000433325 (10:44915457 C>T), RS1000455086 (10:44920077 G>A,T), RS1000598396 (10:44918158 G>A), RS1000776788 (10:44925891 A>G), RS1001083197 (10:44925624 G>A), RS1001310112 (10:44929728 T>G), RS1001313518 (10:44928846 C>G), RS1001520432 (10:44936726 G>A), RS1001580363 (10:44917507 C>A,G,T), RS1001707892 (10:44914073 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002805_3 | Body mass index | 6.000000e-06 |
| GCST003814_27 | Selective IgA deficiency | 9.000000e-06 |
| GCST007094_33 | Diastolic blood pressure | 1.000000e-09 |
| GCST007098_92 | Diastolic blood pressure | 5.000000e-08 |
| GCST007098_93 | Diastolic blood pressure | 4.000000e-07 |
| GCST009545_2 | Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis | 1.000000e-06 |
| GCST010002_286 | Refractive error | 1.000000e-14 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005937 | longitudinal BMI measurement |
| EFO:0006336 | diastolic blood pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | decreases expression, affects methylation | 2 |
| Aflatoxin B1 | decreases expression, increases methylation | 2 |
| 2-palmitoylglycerol | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Arsenic | decreases methylation | 1 |
| Endosulfan | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): lymphopenia, selective IgA deficiency disease